How Long Does Semaglutide Take to Work? The Three Timelines That Get Confused

"How long until it works" sounds like one question. It is three, they run on different clocks, and confusing them is why so many people decide at week three that the medication failed.

Timeline one: the drug reaching full strength

Semaglutide has an elimination half-life of about one week³. A drug reaches steady state after roughly four to five half-lives, so a given dose is at its full, stable concentration around four to five weeks after you start it — not after the first injection.

That is per dose. You are also climbing a ladder. The label's escalation schedule steps the dose every four weeks, and the full maintenance dose of 2.4 mg once weekly is reached at week 17 by design³. So "how long until I am on the real dose" is a four-month answer, not a four-week one, and every step along the way spends its own month coming up to strength.

Timeline two: appetite

This is the one people notice first, and it is the least predictable. Some people describe a clear drop in appetite within days of the first low dose; others feel almost nothing until the second or third step up. Both are normal, and neither predicts how well the drug will eventually work for you.

What is worth knowing: the starting dose is not a treatment dose. It exists to build tolerance to the gastrointestinal side effects, which is why the label starts everyone low and steps up rather than beginning at the effective dose³. If you feel nothing at 0.25 mg, that is the dose doing its actual job. Our dosing and titration guide sets out what the ladder should look like.

Timeline three: the scale — and this one is months

Here the trial data is unambiguous and much slower than the marketing. In STEP-1, the average weight-loss curve climbed steeply for roughly the first eight to nine months before flattening for the rest of the 68-week trial¹. SURMOUNT-1 showed the same shape for tirzepatide across 72 weeks — a steep early phase, then a leveling off in the second half².

Read that carefully, because it cuts both ways. Most of the weight in those trials came off over months, not weeks — so judging the medication at week four is judging it before it has finished arriving. And the flattening later is expected physiology, not failure; we cover that in the GLP-1 weight-loss plateau.

What "it isn't working" usually turns out to be

Four things, in rough order of frequency.

You are early. Week three on a starting dose is not a trial of the medication. It is the on-ramp.

You are not at a maintenance dose yet. 0.25 mg and 0.5 mg are escalation steps. If a provider left you at a starting dose for months, that is worth asking about directly.

The dose is right but the expectation was borrowed from someone else. Trial averages are averages; individual response varies widely, and a slower curve is not a failed one.

Something practical is off — a missed week, a storage problem that spoiled the pen, or a drawn dose that was not the intended dose. Two of those are avoidable: see how to store GLP-1 medication and, if you use compounded vials and a syringe, GLP-1 units to mg conversion, which is where the most common arithmetic error lives.

When to actually raise it with a prescriber

If you have reached a maintenance dose, held it for a couple of months, and the trend is genuinely flat — not one stalled week — that is a real conversation, and it might end in a dose change, a molecule change, or a look at what else is going on. If you are considering the second of those, semaglutide vs tirzepatide sets out how the two compare head to head.

The honest takeaway: the drug is at full strength for a given dose in about four to five weeks, you reach the maintenance dose around week 17, appetite may shift anywhere from days to weeks, and the weight curve in the trials took months. If you are three weeks in and disappointed, you are not looking at a failure — you are looking at the beginning.